Articles

Fed’s Mester says forecast of 3 rate cuts this year is now probably too many

“I was on the record before saying I was at the median [forecast] which was three,” Loretta Mester said Monday. “The developments I’ve seen in the economy right now, I would not think that that’s still appropriate.”

How Ivan Boesky became one of the most infamous figures on Wall Street and the inspiration for Gordon Gekko

Ivan Boesky’s 1986 guilty plea to insider trading, accompanied by a then-record $100 million fine, brought to a close a period of roaring 1980s exorbitance on Wall Street and beyond that became the calling card of the so-called Me Generation.

Target lowers food prices as many shoppers go into grocery debt

“Consumers are feeling pressured,” the big-box retailer acknowledged while lowering prices on 5,000 items.

Fed likely to keep a $6.8 trillion balance sheet by December, says Barclays

Another lasting facet of the pandemic looks to be a very large Federal Reserve balance sheet.

Global stocks hit record highs as more countries join in the rally

More global stocks are joining in the rally, and that’s a good thing — especially for U.S. markets.

Surging shipping costs could complicate Fed’s inflation fight

While supply shortages have eased greatly in the past few years, they have not entirely gone away.

Who pays for long-term care?

People are confused and overestimate Medicare’s role in paying for long-term care

Micron’s stock rises as Morgan Stanley admits its bearish stance ‘was a mistake’

An analyst said he failed to properly appreciate how high-bandwidth memory would drive stock momentum.

Are market-beating fund managers truly skilled or just lucky?

The case for index funds strengthens against the reality that most managers underperform.

Grayscale CEO Michael Sonnenshein steps down as firm’s bitcoin ETF bleeds assets

Grayscale Investments has named a new chief executive as Michael Sonnenshein stepped down after helping to pave the way for spot bitcoin exchange-traded funds that are now posing hot competition for the firm.

Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings

Hims & Hers Health’s stock jumped more than 30% Monday morning after the health and wellness platform said it would offer compounded versions of popular GLP-1 drugs.

As hurricane season arrives, these stocks could present opportunities

With an ”extremely active” hurricane season about to start, key stocks in the home-improvement and consumer-staples industries could present opportunities, according to investing-information website Trading.biz.
1 1,417 1,418 1,419 1,420 1,421 2,589